Section Review Central & Peripheral Nervous Systems: Pharmacological Modulation of Opioid Tolerance

References

• INTURRISI CE: Opioid analgesic therapy in cancer pain. In: Advances in Pain Research and Therapy. Foley KM, Bonica Jj, Ventafridda V (Eds.). New York, Raven Press (1990):133–154.
   Google Scholar
• FOLEY KM: Clinical tolerance to opioids. In: Towards a New Pharmacotherapy of Pain. Basbaum Al, Besson JM (Eds.). Dahlem Konforenzen, Chichester, John Wiley & Sons (1991):181–204. This article gives an overview of tolerance from a clinical perspective.
   Google Scholar
• PASTERNAK GW: Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. (1993) 16:1-18. This review provides a broad overview of the pharmacology of the various opioid receptor subtypes.
   Google Scholar
• EVANS C, KEITH D, MORRISON H, MAGENDZO K, ED-WARDS R: Cloning of a delta-opioid receptor by functional expression. Science (1992) 258:1952-1955. This was the first article, along with that of Kieffer and colleagues, describing the cloning of an opioid receptor. It describes the cloning of DOR-1, corresponding to the delta receptor.
   Google Scholar
• KIEFFER B, BEFORT K, GARERIAUX-RUFF C, HIRTH C: The deha-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterisation. Proc. Natl. Acad. Scl. USA (1992) 89:12048-12052. This article, along with that of Evans and colleagues, was the first to describe the cloning of an opioid receptor. It describes the cloning of DOR-1, corresponding to the delta receptor.
   Google Scholar
• CHEN Y, MESTEK A, LIU j, HURLEY A, YU L: Molecular cloning and functional expression of a mu-opioid re-ceptor from rat brain. Mol. Pharmacol. (1993) 44:8–12.
   PubMed Web of Science ®Google Scholar
• WANG JB, MEI Y, EPPLER CM, GREGOR P, SPIVAK CE, UHLGR: Mu opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA (1993) 90:10230–10234.
   PubMed Web of Science ®Google Scholar
• YASUDA K, RAYNOR K, KONG H, BREDER C, TAKEDA J,REISINE T, BELL G: Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA (1993) 90:6736–6740.
   PubMed Web of Science ®Google Scholar
• FUKUDA K, KATTO S, MORI K, NISHI M, TAKESHIMA H:Primary structures and expression from cDNAs of rat opioid receptor from 6-and ti-subtypes. FEBS Lett. (1993) 327:311–314.
   PubMed Web of Science ®Google Scholar
• THOMPSON RC, MANSOUR A, AKIL H, WATSON SJ: Clon-ing and pharmacological characterization of a rat 1.t opioid receptor. Neuron (1993) 11:1–20.
   Google Scholar
• TAKESHIMA H, FUKUDA K, KATO S, MOM K: cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa subtype-selective ligands. FEBS Lett. (1993) 330:77–80.
   PubMed Web of Science ®Google Scholar
• MINAMI M, TOYA T, ICATA0 Y, MAEKAWA K, NAKAMURAS, ONOGI T, KANEKO S, SATOH M: Cloning and expres-sion of a cDNA for the rat kappa-opioid receptor. FEBS Lett. (1993) 329:291–295.
   PubMed Web of Science ®Google Scholar
• MENG F, XIE G, THOMPSON R, MANSOUR A, GOLDSTEINA, WATSON SJ, AKIL H: Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl, Acad. Sci. USA (1993) 90:9954–9958.
   PubMed Web of Science ®Google Scholar
• MOLLERAU C, PARMENITER M, MAILLEUX P, BUTOUR JL,MOISAND C, CHALON P, CAPUT D, VASSART G, MEUNNIER JC: ORL1, a novel member of the opioid family: cloning, functional expression and localisation_ FEBS Lett. (1994) 341:33-38.
   Google Scholar
• WANG BJ, JOHNSON PS, IMAI Y, PERSICO AM, OZENBER-GER BA, EPPLER CM, UHL GR: cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. (1994) 348:75–79.
   PubMed Web of Science ®Google Scholar
• FUKUDA K, KATO S, MOM K, NISHI M, TAKESHIMA H, IWABE N, MIYATA T, HOUTANI T, SUGIMOTI T: cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. (1994) 343:42–46.
   PubMed Web of Science ®Google Scholar
• UHL GR, CHILDERS SR, PASTERNAK GW: An opiate recep-tor gene family reunion. Trends Neurosci. (1994) 17:89–93.
   PubMed Web of Science ®Google Scholar
• PAN YX, CHENG J, PASTERNAK GW: Isolation and char-acterization of a Icappa3 related opioid receptor. Regu-latory Peptides (1994) 54:217–218.
   Google Scholar
• RAYNOR K, KONG H, IIINES J, KONG G, BENOVIC J, YASUDA K, BELL GI, REISINE T: Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J. Pharmacol. Exp. Ther. (1994) 270:1381–1386.
   PubMed Web of Science ®Google Scholar
• SIIARMA SK, NIRENBERG M, KLEE W: Morphine receptorsas regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. USA (1975) 72:590–594.
   PubMed Web of Science ®Google Scholar
• PUI lEARCICEN P, WERLING LL, COX BM: Effects ofchronic morphine exposure on opioid inhibition of acienyly1 cyclase in 7315c cell membranes: a useful model for the study of tolerance at 1.1 opioid receptors. Mol. Pharmacol. (1988) 33:520–527.
   PubMedGoogle Scholar
• TOLL L: Mu-opioid receptor binding in intact SH-SY5Yneuroblastoma cells. Eur. J. Pharmacol. (1990) 176:213–217.
   PubMed Web of Science ®Google Scholar
• LAW PY, HOM DS, LOH HH: Effect of chronic D-A1a2,D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblas-toma x glioma NG108-15 hybrid cells. J. Pharmacol. Exp. Ther. (1991) 256:710–716.
   PubMed Web of Science ®Google Scholar
• KOLESNIKOV YA, FERKANY J, PASTERNAK GW: Blockadeof mu and kappa' opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci. (1993) 53:1489–1494.
   PubMed Web of Science ®Google Scholar
• ELLIOTT KJ, MINAMI N, KOLESNIKOV YA, PASTERNAK GW, INTURRISI CE: The NMDA receptor antagonists, LY 274614 and MK-801, and the nitric oxide synthase Inhibitor, N°-nitro-L-arginine, attenuate analgesic tol-erance to the mu-opioid morphine but not to kappa opioids. Pain (1994) 56:69-75. This article describes the competitive NMDA antagonist LY274614 and it actions on opioid tolerance.
   Google Scholar
• BABEY AM, KOLESNIKOV Y, CHENG J, INTURRISI CE, esTRIFILLE 11h, RR, PASTERNAK GW: Nitric oxide and opioid tolerance. Neuropharmacol. (1994) 33:1463-1470. This article provides a detailed description of the actions of NOS inhibitors on enzyme activity and presents data regarding the ability of L-arginine to enhance morphine tolerance.
   Google Scholar
• KOLESNIKOV YA, PICK CG, CISZEWSKA G, PASTERNAK GW: Blockade of tolerance to morphine but not to tc opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA (1993) 90:5162-5166. Although a brief report was published earlier (Kolesnikov et al., 1992), this article presents the first detailed descriptions of the actions of nitric oxide synthase inhibitors on opioid tolerance.
   Google Scholar
• PASTERNAK GW, KOLESNIKOV YA, BABEY AM: Perspec-tives on the NMDA/NO cascade and opioid tolerance. Neuropsychopharmacol. (1995). In press.
   Google Scholar
• TRUJLLLO KA, AKIL H: Inhibition of morphine tolerance ••and dependence by the NMDA receptor antagonistMK-801. Science (1991) 251:85-87. This article was one of the first documenting the ability of NMDA antagonists to modulate opioid tolerance.
   Google Scholar
• TRUJILLO KA, AKIL H: Inhibition of opioid tolerance by non-competitive N-methyl-D-aspartate receptor an-tagonists. Brain Res. (1994) 633:178–188.
   PubMed Web of Science ®Google Scholar
• MAREK P, BEN-ELIYAHU S, GOLD M, LIEBESKIND JC: Excitatory amino acid antagonists (kynurenic acid andMK-801) attenuate the development of morphine toler-ance in the rat. Brain Res. (1991) 547:77-81. This was one of the first observations that blockade of NMDA receptors could influence opioid tolerance.
   Google Scholar
• TISEO PJ, INTURRISI CE: Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. (1993) 264:1090–1096.
   PubMed Web of Science ®Google Scholar
• KOLESNIKOV YA, PICK CG, PASTERNAK GW: NG-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharma-col. (1992) 221:399–400.
   PubMed Web of Science ®Google Scholar
• TISEO PJ, CHENG J, PASTERNAK GW, INTURRISI CE: Modu-lation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY272614: Assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. (1994) 268:195–201.
   PubMed Web of Science ®Google Scholar
• Euto'rr KJ, HYNANSKY A, INTURRISI CE: Dextromethor-phan attenuates and reverses analgesic tolerance to morphine. Pain (1994) 59: 361–368. 29.
   Google Scholar
• ••
   Google Scholar
• EttioTT KJ, MAN A, INTURRISI CE: Ketamine and fel- bamate attenuate tolerance to morphine analgesia. Col-lege on Problems of Drug Dependence (1995). Abstract.
   Google Scholar
• INTURRISI CE: NMDA receptors, nitric oxide and opioid tolerance. Reg. Peptides (1994) 54:129–130.
   Web of Science ®Google Scholar
• VAUPEL DB, KIMES AW, LONDON ED: Comparison of 7-nitroinda2ole with other nitric oxide synthase inhibi-tors as attenuators of opioid withdrawaL Psychopharma-col. (1995). In press.
   Google Scholar
• BREDT DS, SNYDER SH: Nitric oxide: a novel neuronal messenger. Neuron (1992) 8:3-11. This article provides an excellent review of nitric oxide and many of its actions.
   Google Scholar
• BADING H, GINTY DD, GREENBERG ME: Regulation of gene expression in hippocarapal neurons by distinct calcium signaling pathways. Science (1993) 260:181–186.
   PubMed Web of Science ®Google Scholar
• RASMUSSEN K, BRODSKY M, INTURRISI C: NMDA antago-nists and clonidine block clos expression during mor-phine withdrawal. Synapse (1995). In press.
   Google Scholar
• MELDRUM B, GARTHWAITE J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Itu Trends in Pharmacological Sciences: The pharmacology of excitatory amino acids. A special report. Lodge D, Collin-gridge L (Eds.). Elsevier, Cambridge, UK (1991):54–62.
   Google Scholar
• WOOLF CJ, THOMPSON SWN: The induction and main-tenance of central sensitization is dependent on N-methyl-D-aspartate receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain (1991) 44:293–299.
   PubMed Web of Science ®Google Scholar
• MAO J, PRICE DD, MAYER DJ, LU J, HAYES RL: IntrathecalMK-801 and local nerve anesthesia synergistically re-duce nociceptive behaviors in rats with experimental peripheral motoneuropathy. Brain Res. (1992) 576:254–262.
   PubMed Web of Science ®Google Scholar
• MAO J, PRICE DD, HAYES RL, LU J, MAYER DJ, FRENK H:Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral motoneuropathy. Brain Res. (1993) 605:164–168.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO T, YAKSH TL: Studies on the spinal interac-tion of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic motoneuropathy. Neurosci. Lett. (1992) 135:67–70.
   PubMed Web of Science ®Google Scholar
• KRISTENSEN JD, SVENSSON B, GORDH T: The NMDA-re-ceptor antagonist CPP abolishes neurogenic `wind-up pain' after intrathecal administration in humans. Pain (1992) 51:249–253.
   PubMed Web of Science ®Google Scholar
• KOLESNIKOV YA, MACCECHINI ML, PASTERNAK GW: 1-Amhiocyclopropate carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci. (1994) 55:1393–1398.
   PubMed Web of Science ®Google Scholar
• MOORE PK, OLUYOMI AO, BABBEDGE RC, WALLACE P,HART SL: L-NG-nitroarginine methyl ester exhibits anti-nociceptive activity lathe mouse. Br.J.Pharmacol. (1991) 102:198–202.
   PubMed Web of Science ®Google Scholar
• EttioTT KJ, 10ESSELMAN D, FOLEY KM, INTURRISI CE:IntrathecalNG-methyl-L-arginine acetate (NMA), a nitric oxide synthase (NOS) inhibitor, is antinociceptive in the mouse formalin test. Amer. Pain Soc. Abstr. (1992). Abstract No. 153.
   Google Scholar
• HALEY JE, DICKENSON AH, SCHACTER M: Electrophysi-°logical evidence for a role of nitric oxide in prolonged chemical nociception lathe rat Neuropharmacol. (1992) 31:251–258.
   Google Scholar
• KITTO KF, HALEY JE, WILCOX GL: Involvement of nitricoxide in spinally mediated hyperalgesia in the mouse. Neurosci. Lett. (1992) 148:1–5.
   PubMed Web of Science ®Google Scholar
• MELLER ST, PECHMAN PS, GEBHART GF, MAVES TJ: Nitricoxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat. Neuroscience (1992) 50:7–10.
   PubMed Web of Science ®Google Scholar
• RADHAKRISHNAN V, HENRY JL: L-NAME blocks re-sponses to NMDA, substance P and noxious cutaneous stimuli in cat dorsal horn. NeumReport (1993) 4:323–326.
   PubMed Web of Science ®Google Scholar
• BHARGAVA HN, THORAT SN: Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U50,488H, a K-opioid receptor agonist, in the mouse. Brain Res. (1994) 649:111–116.
   PubMed Web of Science ®Google Scholar
• THORAT SN, REDDY PL, BHARGAVA HN: Evidence for the role of nitric oxide in ic-opiate tolerance in mice. Brain Res. (1993) 621:171–174.
   PubMed Web of Science ®Google Scholar
• GUTSTEIN HB, TRUJILLO KA: MK-801 inhibits the devel-opment of morphine tolerance at spinal sites. Brain Res. (1993) 626:332–334.
   PubMed Web of Science ®Google Scholar
• WATKINS LR, KINSCHECK IB, MAYER DJ: Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science (1984) 224:395–396.
   PubMed Web of Science ®Google Scholar
• PICK CG, CHENG J, PAUL D, PASTERNAK GW: Genetic influences in opioid analgesic sensitivity in mice. Brain Res. (1991) 566:295–298.
   PubMed Web of Science ®Google Scholar
• NETZER R, PFLIMLIN P, TRUBE G: Dextromethorphan blocks N-methyl-D-as partate-induced currents and volt-age-operated inward currents in cultured cortical neu-rons. Eur. J. Pharmacol. (1993) 238:209–216.
   PubMed Web of Science ®Google Scholar
• FERKANY JW, BOROSKY SH, CLISSOLD DB, PONTECORVO MJ: Dextromethorphan inhibits NMDA-induced convul-sions. Eur. J. Pharmacol. (1988) 151:151–154.
   PubMed Web of Science ®Google Scholar
• CHURCH J, LODGE D, BERRY SC: Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur. J. Pharmacol. (1985) 111:185–190.
   PubMed Web of Science ®Google Scholar
• CHOI DW: Dextrorphan and dextromethorphan attenu-ate glutamate neurotoxicity. Brain Res. (1987) 403:333-336. DICKENSON AH, SULLIVAN AF, STANFA LC, MCQUAY HJ: Dextromethorphan and levorphanol on dorsal horn nociceptive neurones in the rat. Neuropharmacol. (1991) 30:1303–1308.
   Google Scholar
• ELLIOTT KJ, HYNANSKY A, FOLEY KM, INTURRISI CE: Dextromethorphan is antinociceptive in the mouse formalin test Amer. Pain. Soc. Abstr. (1993). Abstract No.
   Google Scholar
• ELLIOTT' KJ, BRODSKY M, HYNANSKY A, FOLEY KM, INTURRISI: Dextromethorphan suppresses both for-malin-induced nociceptive behavior and formalin-in-duced increase in CNS c-fos mRNA. Pain (1995). In press.
   Google Scholar
• BONUCCELLI U, DEL DOTTO P, PICCINI P, BEHGE F,CORSINI GU, MURATORI° A: Dextromethorphan and parkinsonism [Letter]. Lancet (1992) 340:53.
   PubMed Web of Science ®Google Scholar
• SAENZ R, TANNER CM: A preliminary study of dex-tromethorphan (DM) as adjunctive therapy in Parkin-son's disease (PD). Neurology (1993) 43:A155.
   Web of Science ®Google Scholar
• FISHER RS, CYSYK BJ, LESSER RP, PONTECORVO MJ, FERKANY jr, SCHWERDT PR, HART J, GORDON B: Dex-tromethorphan for treatment of complex partial sei-zures. Neurology (1990) 40:547–549.
   PubMed Web of Science ®Google Scholar
• ALBERS GW, SAENZ RE, MOSES JA, CHOI DW: Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Stroke (1991) 22: 1075–1077.1
   Google Scholar
• SCHMITT B, STEINMANN B, GITZELMANN R, THUN-HO-HENSTEIN L, MASCHER H, DUMERMUTH G: Nonketoic hyperglycinernia: Clinical and electrophysiological ef-fects of dextromethorphan, an antagonist of the NMDA receptor. Neurology (1993) 43:421–424.
   PubMed Web of Science ®Google Scholar
• PRICE DD, MAO J, FRENK H, MAYER DJ: The N-methyl-D-as partate receptor antagonist dextromethorphan selec-tively reduces temporal summation of second pain in man. Pain (1994) 59:165–174.
   PubMed Web of Science ®Google Scholar
• MCQUAY HJ, CARROLL D, JADAD AR, GLYNN CJ, JACK T,MOORE RA, WIFFEN PJ: Dextromethorphan for the treat-ment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain (1994) 59:127–133.
   PubMed Web of Science ®Google Scholar
• MOORE PK, BABBEDGE RC, WALLACE P, GAFFEN ZA, HART SL: 7-Nitroinr127ole, an inhibitor of nitric oxide sythase, exhibits antinociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol, (1993) 108:296-297. This article describes the actions of 7NI and its selectivity towards the neuronal NOS. It provides evidence suggesting that highly selective NOS inhibitors might be possible. Gavril W Pasternak, The George C Cotzias Laboratory of Neuro-On-cology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. Charles E Inturrisi, Department of Pharmacology, Cornell University Medical College, 1300 York Ave-nue, New York, NY 10021, USA.
   Google Scholar